Skip to main content

Table 2 Therapeutic response to Co-artesiane®

From: Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane®) for the treatment of uncomplicated Plasmodium falciparum in children in Zambia

Variable

Chongwe N = 54

Chipata N = 57

 

n

%

n

%

Exclusion

0

0

1

1.8

Loss to follow-up

0

0

6

10.5

Withdrawal

0

0

2

3.5

ETFU

0

0

0

0

LCFU

8

14.8

8

14

LPFU

19

35.2

6

10.5

ACPRU

27

50

39

68.4

Re-infections

20

37

10

17.5

LTFC

0

0

0

0

Inadequate sample

7

 

3

 

Evaluable

47

 

44

 

ACPRC

47

100

44

100